MS. Schwartz, MS. Frank; A. Yanoff; R. Morecki, Atenolol-associated cholestasis., in Am J Gastroenterol, vol. 84, n. 9, Set 1989, pp. 1084-6, PMID2773903.
SW. Yusuf, RM. Mishra, Hepatic dysfunction associated with atenolol., in Lancet, vol. 346, n. 8968, Lug 1995, p. 192, PMID7603264.
JR. Cove-Smith, CA. Kirk, CNS-related side-effects with metoprolol and atenolol., in Eur J Clin Pharmacol, 28 Suppl, 1985, pp. 69-72, PMID4054193.
W. Gandy, Severe epinephrine-propranolol interaction., in Ann Emerg Med, vol. 18, n. 1, Gen 1989, pp. 98-9, PMID2910169.
R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, Feb 1996, pp. 69-77, PMID8852521.
KJ. Thorley, J. McAinsh, Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy., in Biopharm Drug Dispos, vol. 4, n. 3, pp. 299-301, PMID6626704.
WB. White, JW. Andreoli; SH. Wong; RD. Cohn, Atenolol in human plasma and breast milk., in Obstet Gynecol, vol. 63, 3 Suppl, Mar 1984, pp. 42S-44S, PMID6700880.
G. Haeusler, Pharmacology of beta-blockers: classical aspects and recent developments., in J Cardiovasc Pharmacol, 16 Suppl 5, 1990, pp. S1-9, PMID11527109.